Axonal loss in multiple sclerosis: A pathological survey of the corticospinal and sensory tracts

Brain

Volumn 127, Issue 5, 2004, Pages 1009-1018

  DeLuca, Gabriele C ^a,c   Ebers, G C ^a   Esiri, M M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Axonal loss; Multiple sclerosis; Neuropathology

Indexed keywords

ADULT; AGED; AUTOPSY; AXONAL INJURY; CELL DENSITY; CELL LOSS; CELL POPULATION; CERVICAL SPINAL CORD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LUMBAR SPINAL CORD; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MULTIPLE SCLEROSIS; NERVE TRACT; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRAMIDAL TRACT; QUANTITATIVE ANALYSIS; REVIEW; SENSORY NERVE;

ADULT; AGED; AGED, 80 AND OVER; AXONS; CASE-CONTROL STUDIES; FEMALE; GANGLIA, SENSORY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PYRAMIDAL TRACTS; SPINAL CORD; STAINING AND LABELING;

EID: 2442555263     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh118     Document Type: Review

References (27)

1. Bjartmar C, Yin X, Trapp BD. Axonal pathology in myelin disorders. J Neurocytol 1999; 28: 383-95.
2. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 793-901.
3. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001; 57: 1248-52.
4. Charcot M. Histologie de la sclerose en plaques. Gaz Hop (Paris) 1868; 141: 554-8.
5. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 188: 1583-92.
6. Dawson JW. The histology of disseminated sclerosis. Trans R Soc Edinb 1916; 50: 517-740.
7. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-77.
8. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000a; 47: 391-5.
9. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000b; 123: 1845-9.
10. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
11. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995; 45: 255-60.
12. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis; a post-mortern study. Neuropathol Appl Neurobiol 1999; 25: 459-67.
13. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 2002; 125: 551-61.
14. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998; 280: 1610-3.
15. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000; 157: 267-76.
16. Lassmann H. Axonal injury in multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 695-7.
17. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701-8.
18. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308-17.
19. Lumsden CE. The immunogenesis of the multiple sclerosis plaque. Brain Res 1971; 28: 365-90.
20. McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal. 2nd edn. Baltimore: Williams and Wilkins; 1972.
21. Poser CM. Pathogenesis of multiple sclerosis. A critical reappraisal. Acta Neuropathol (Berl) 1986; 71: 1-10.
22. Scherer S. Axonal pathology in demyelinating diseases. Ann Neurol 1999; 45: 6-7.
23. Shi R, Blight AR. Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. J Neurophysiol 1996; 76: 1572-80.
24. Simon JK, Kinkel RP, Jacobs L, Bub L, Simonian N. A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000; 54: 1155-60.
25. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
26. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002; 61: 23-32.
27. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 1998; 18: 1953-62.